Skip to main content
Find a Lawyer

United States Ninth Circuit


BROUDO v. DURA PHARMS., INC., 01-57136

A complaint satisfied the loss causation element of a Section 10(b) violation of the Securities and Exchange Act of 1934 with respect to a device for asthma medication delivery, and the district court abused its discretion in not permitting plaintiffs to amend the complaint to include additional allegations regarding antibiotic sales.

Appellate Information

  • Argued 02/04/2003
  • Decided 08/05/2003
  • Published 08/05/2003

Judges

  • ARCHER, Senior Circuit Judge., Before PREGERSON, REINHARDT, and ARCHER, Circuit Judges.

Court

  • United States Ninth Circuit

Counsel

  • For Appellant:
  • William S. Lerach,Jan M. Adler, Eric A. Isaacson, Henry Rosen, Tor Gronborg, Joseph D. Daley, Milberg Weiss Bershad Hynes & Lerach LLP, Alan Schulman, Blair A. Nicholas, Bernstein Litowitz Berger & Grossmann, LLP, San Diego, CA;  Steven J. Toll, Cohen, Milstein, Hausfeld & Toll, P.L.L.C., Seattle, WA, for the plaintiffs-appellants.

  • For Appellees:
  • William F. Sullivan, Christopher H. McGrath, Sean T. Prosser, Colleen E. Huschke, Brobeck, Phleger & Harrison, LLP, San Diego, CA, for the defendants-appellees.
Copied to clipboard